Organon Co (OGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Organon Co Stock (OGN) Company Profile

Healthcare (1200)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Prossima data di guadagno

Ultimi documenti SEC

OGN's Discussions on Twitter

Confronta OGN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OGN Organon Co	15.98	4.15B	6.41B	1.30B	646.00M	2.29
LLY Lilly Eli Co	788.19	752.65B	40.86B	8.37B	-2.28B	5.4193
NVO Novo Nordisk Adr	106.13	471.56B	39.36B	13.79B	9.83B	2.4077
JNJ Johnson Johnson	155.40	353.35B	87.70B	14.68B	19.03B	13.47
ABBV Abbvie Inc	183.08	323.72B	55.53B	5.12B	15.62B	3.65
MRK Merck Co Inc	103.12	260.72B	63.17B	12.15B	14.84B	1.80

Organon Co Stock (OGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-09-06	Downgrade	JP Morgan	Neutral → Underweight
2023-11-03	Downgrade	Goldman	Buy → Neutral
2023-09-21	Iniziato	Barclays	Overweight
2023-03-16	Iniziato	Raymond James	Outperform
2022-10-14	Downgrade	BofA Securities	Neutral → Underperform
2022-09-06	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-08-05	Downgrade	BofA Securities	Buy → Neutral
2022-04-27	Iniziato	Goldman	Buy
2022-04-06	Ripresa	Morgan Stanley	Equal-Weight
2021-10-07	Iniziato	Piper Sandler	Neutral
2021-09-01	Iniziato	BofA Securities	Buy
2021-07-22	Iniziato	Citigroup	Buy
2021-06-15	Iniziato	JP Morgan	Neutral
2021-06-11	Iniziato	Morgan Stanley	Equal-Weight
2021-06-10	Iniziato	Evercore ISI	Outperform

Mostra tutto

Organon Co Borsa (OGN) Ultime notizie

Organon Co Azioni (OGN) Dati Finanziari

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Confronta OGN con altri titoli

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Borsa (OGN) Ultime notizie

Algert Global LLC Has $2.20 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Organon & Co. (OGN): An Oversold Healthcare Stock to Invest In Now - Insider Monkey

Cerity Partners LLC Has $12.77 Million Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

(OGN) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Organon & Co. (NYSE:OGN) Stock Position Lifted by Victory Capital Management Inc. - MarketBeat

Massachusetts Financial Services Co. MA Sells 332,614 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune

Thompson Siegel & Walmsley LLC Raises Stake in Organon & Co. (NYSE:OGN) - MarketBeat

Foundry Partners LLC Takes $7.64 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat

Reach For A Dream and Organon Collaborate to Launch Dream Room at Rahima Moosa Mother and Child Hospital - Media Update

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Organon partners with Egyptian Drug Authority to advance women’s health and family planning in Egypt - ZAWYA

Beddow Capital Management Inc. Raises Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Organon: 7% Yield, 4x P/E, Big Upside Potential (NYSE:OGN) - Seeking Alpha

(OGN) Proactive Strategies - Stock Traders Daily

Organon & Co. (NYSE:OGN) Shares Sold by Principal Financial Group Inc. - MarketBeat

Organon & Co. (NYSE:OGN) Stock Holdings Decreased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat

Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade) - Seeking Alpha

Organon & Co (OGN) Stock Price Down 3.48% on Nov 12 - GuruFocus.com

Amalgamated Bank Sells 34,385 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Los Angeles Capital Management LLC Boosts Stake in Organon & Co. (NYSE:OGN) - MarketBeat

Acorn Financial Advisory Services Inc. ADV Takes $743,000 Position in Organon & Co. (NYSE:OGN) - MarketBeat

Van ECK Associates Corp Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Philip James Wealth Mangement LLC Invests $15.39 Million in Organon & Co. (NYSE:OGN) - MarketBeat

Ex-Dividend Reminder: American Water Works, Essential Utilities Inc and Organon - Nasdaq

Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem - Yahoo Finance

Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - Simply Wall St

Organon & Co (OGN) Stock Price Up 2.82% on Nov 7 - GuruFocus.com

FDA extends Organon's VTAMA cream review to March 2025 By Investing.com - Investing.com Canada

Organon & Co. (NYSE:OGN) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Earnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance

Relative Strength Alert For Organon - Nasdaq

Organon updates outlook as FDA delays VTAMA label expansion - MSN

Organon reports FDA extension of target action date of review of Vtama sNDA - TipRanks

Organon’s VTAMA Cream FDA Review Extended to 2025 - TipRanks

Organon stock on watch as FDA delays VTAMA label (OGN:NYSE) - Seeking Alpha

FDA extends Organon's VTAMA cream review to March 2025 - Investing.com

(tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older - Business Wire

Organon's SWOT analysis: stock outlook amid VTAMA potential and biosimilar growth - Investing.com

Organon & Co (OGN) Stock Price Down 6.38% on Nov 4 - GuruFocus.com

Organon & Co. (NYSE:OGN) Trading Down 4.4%Should You Sell? - MarketBeat

The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Simply Wall St

Organon China’s License and Supply Agreement with Shanghai Bao Pharmaceuticals - Global Legal Chronicle

(OGN) Technical Pivots with Risk Controls - Stock Traders Daily

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28 - Yahoo Finance

Organon (OGN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN

Private Management Group Inc. Has $36.23 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

FDA accepts Organon BLA for Prolia/Xgeva biosimilar - MSN

Organon Third Quarter 2024 Earnings: EPS: US$1.39 (vs US$0.23 in 3Q 2023) - Yahoo Finance

Organon & Co. (NYSE:OGN) to Issue $0.28 Quarterly Dividend - MarketBeat

Organon Co Azioni (OGN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a OGN